In our current study, we have identified a lncRNA CASC19 which is notably upregulated in pancreatic tumor tissue and pancreatic cancer cell lines and is associated with advanced stages of the disease and poor patient survival. Here, CASC19 is linked to familial pancreatic carcinoma.